Home » Newsletters » BioWorld

BioWorld

Dec. 28, 1998

View Archived Issues

Other News To Note

Science Scan: Mice Blinded By Disrupting Gene For Retinal Epithelium Offer Human

Biogen CEO Resigns, Cites Personal Reasons

Holiday Notice

SmithKline Holds Up Trials Of RA Drug In Idec Deal

Vision Firm Buying Out Transcend Therapeutics

FDA Rejects Herpes Drug; Avanir's Stock Plummets

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...